Financials
- Market Capitalization 81.76 M
- Employee 69
- Founded 2012
- CEO N/A
- Website www.ranitherapeutics.com
- Headquarter California, United States
- FIGI BBG011R6PZ44
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4082 | CSBR Champions Oncology, Inc. - Common Stock | 5.78 USD | -0.52% | -2.86% | -10.94% | -28.20% | 80.27 M USD | ||
| 4099 | HRTX Heron Therapeutics, Inc. - Common Stock | 0.42 USD | 0.00% | 0.00% | 0.00% | -80.19% | 79.50 M USD | ||
| 4104 | ENTX Entera Bio Ltd. - Ordinary Shares | 1.66 USD | +1.22% | -1.19% | +32.80% | -6.21% | 81.71 M USD | ||
| 4116 | GANX Gain Therapeutics, Inc. - Common Stock | 1.82 USD | +3.41% | -0.55% | +6.43% | -2.15% | 77.63 M USD |
Frequently asked questions about Rani Therapeutics Holdings, Inc. - Class A Common Stock
What is the Rani Therapeutics Holdings, Inc. - Class A Common Stock stock price today?
The current price of Rani Therapeutics Holdings, Inc. - Class A Common Stock (RANI) is 0.66. Over the past 24 hours, the stock has changed by +4.76%. Follow the RANI chart for real-time price dynamics.
What is the stock ticker of Rani Therapeutics Holdings, Inc. - Class A Common Stock?
Rani Therapeutics Holdings, Inc. - Class A Common Stock trades under the ticker RANI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Rani Therapeutics Holdings, Inc. - Class A Common Stock stock going up?
RANI has changed by -15.38% over the last week, -17.50% over the last month, and +34.69% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Rani Therapeutics Holdings, Inc. - Class A Common Stock net income for the last quarter?
Rani Therapeutics Holdings, Inc. - Class A Common Stock reported net income of -7.03 M for the last quarter. The previous quarter showed -10.3 M, which means net income changed by +31.75%.
How many employees does Rani Therapeutics Holdings, Inc. - Class A Common Stock have?
As of the latest available data, Rani Therapeutics Holdings, Inc. - Class A Common Stock has 69 employees. Workforce size can provide additional context about the company's scale and operations.
What is Rani Therapeutics Holdings, Inc. - Class A Common Stock EBITDA?
Rani Therapeutics Holdings, Inc. - Class A Common Stock EBITDA is -8.38 M, and its EBITDA margin is -490.81%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Rani Therapeutics Holdings, Inc. - Class A Common Stock stock?
You can buy Rani Therapeutics Holdings, Inc. - Class A Common Stock (RANI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Rani Therapeutics Holdings, Inc. - Class A Common Stock stock?
Investing in Rani Therapeutics Holdings, Inc. - Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RANI chart and related analysis on metatrader.com as part of your research.